1. Home
  2. OC vs CYTK Comparison

OC vs CYTK Comparison

Compare OC & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Owens Corning Inc New

OC

Owens Corning Inc New

HOLD

Current Price

$128.11

Market Cap

9.6B

Sector

Industrials

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$78.18

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OC
CYTK
Founded
1938
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
10.4B
IPO Year
2006
2004

Fundamental Metrics

Financial Performance
Metric
OC
CYTK
Price
$128.11
$78.18
Analyst Decision
Buy
Strong Buy
Analyst Count
11
19
Target Price
$145.27
$89.26
AVG Volume (30 Days)
968.2K
1.7M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
2.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,368,000.00
Revenue This Year
N/A
$7.37
Revenue Next Year
$3.72
$310.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$97.53
$31.99
52 Week High
$159.42
$80.20

Technical Indicators

Market Signals
Indicator
OC
CYTK
Relative Strength Index (RSI) 59.18 62.37
Support Level $114.43 $59.07
Resistance Level $129.53 $79.66
Average True Range (ATR) 4.61 3.20
MACD 0.73 0.51
Stochastic Oscillator 78.64 83.65

Price Performance

Historical Comparison
OC
CYTK

About OC Owens Corning Inc New

Owens-Corning Inc is a building products company that offers roofing products and systems, insulation products (hermal and acoustical batts, loose fill insulation, spray foam insulation, wet use chopped strand, etc.), and doors and door systems. The company's reportable segments are: Roofing, Insulation, and Doors. Maximum revenue is generated from the Roofing segment, which manufactures and sells residential roofing shingles, oxidized asphalt materials, roofing components, and composite lumber mainly used in residential construction. This segment also manufactures and sells glass mat and specialty veil materials used in building and construction applications. Geographically, the company generates maximum revenue from the United States, followed by Europe, Asia-Pacific, and other markets.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: